Milind Kamkolkar

Venture Partner • RA Capital Management

Milind Kamkolkar is a seasoned entrepreneur, investor, Board Member, and Fortune 500 C-suite executive. Milind’s career has spanned big pharma, big and boutique management consulting organizations, and numerous technology startup companies focused on the intersection of health, AI, and data.

Milind is co-founder and Chief Business Officer of Network Bio, a company transforming precision medicine by developing the US Biobank. Before this, Milind co-founded Paradigm, a company that raised 203.5M USD for Series A in 2022, focused on creating equitable access to clinical trials as a treatment option for any patient, anywhere. Prior to that, Milind was the CDO of Cellarity, a Flagship Pioneering biotechnology company who are rewriting the rules of drug creation by unraveling the complexity of disease biology at the cellular level. At Flagship, Milind also supported numerous AI for drug discovery initiatives.

Milind was the first enterprise Chief Data Officer in the pharmaceutical industry at Sanofi and as VP of AI & Behavioral Science, launched the role of AI & Data science at an enterprise level at Novartis. Milind is also on the Board of Directors of Castor and Turbine, two tech companies specializing in improving clinical trials and drug discovery.

Milind is a featured speaker; TedX, Top 100 Leaders in AI, Business Transformation Top 150 Leaders, and a thought leader in Digital Health, AI & Big Data. He has also served as an Honorary Lecturer for physician entrepreneurship at BartsX, Faculty at Exponential Medicine, and a Former Special Advisor to the UN Global Sustainable Development Goals.

In his spare time, Milind works on technology approaches to overcome challenges facing neurodiverse needs, sustainability, and wellness.